Redox Enzymes of the Thioredoxin Family as Potential and Novel Markers in Pemphigus.


Journal

Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826

Informations de publication

Date de publication:
2021
Historique:
received: 27 11 2020
revised: 03 02 2021
accepted: 23 03 2021
entrez: 19 4 2021
pubmed: 20 4 2021
medline: 29 5 2021
Statut: epublish

Résumé

Pemphigus vulgaris (PV) is a severe autoimmune blistering disease affecting both skin and mucous membranes. Its pathogenesis is related to IgG autoantibodies primarily targeting the cellular adhesion protein desmoglein (Dsg) 3, one of the major desmosome components. Impaired redox regulation is considered a major player in the pathogenesis of autoimmune diseases such as pemphigus by enhancing inflammation and breakdown of immunological tolerance by structural protein modifications. Despite many recent advances, local and systemic redox profiles that characterize the immune response in pemphigus are virtually unknown but potentially crucial in further advancing our understanding of redox-dependent modifications that eventually lead to clinical manifestation. Here, we have analyzed the individual expression pattern of four major redox enzymes that are members of the thioredoxin (Trx) fold superfamily (peroxiredoxins (Prxs) 1 and 4, glutaredoxin (Grx) 2, and Trx1) in serum and PBMCs as well as their distribution in the skin of pemphigus patients compared to healthy controls. We show that in groups of five pemphigus patients, Prx1 is upregulated in both serum and PBMCs, while its epithelial distribution remains within the spinous epithelial layer. Expression of Grx2 and Prx4 is both reduced in serum and PBMCs, while their distinct and similar expression in the skin changes from an even distribution throughout the basal layer (healthy) to ubiquitous nuclear localization in pemphigus patients. In PV patients, Trx1 is secreted into serum, and cellular distribution appears membrane-bound and cytosolic compared to healthy controls. We furthermore showed that a 3D

Identifiants

pubmed: 33868574
doi: 10.1155/2021/6672693
pmc: PMC8032527
doi:

Substances chimiques

Thioredoxins 52500-60-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6672693

Informations de copyright

Copyright © 2021 P. Sliwiak et al.

Déclaration de conflit d'intérêts

The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS One. 2014 Aug 19;9(8):e105529
pubmed: 25137134
Biochem Biophys Res Commun. 2004 Jul 2;319(3):801-9
pubmed: 15184054
Free Radic Biol Med. 2018 Sep;125:36-43
pubmed: 29524605
In Vivo. 2019 Jul-Aug;33(4):1011-1026
pubmed: 31280189
Drugs. 2018 Oct;78(15):1527-1548
pubmed: 30238396
Autoimmunity. 2016 Jun;49(4):248-57
pubmed: 26911801
Antioxid Redox Signal. 2008 Mar;10(3):547-57
pubmed: 18092940
Circulation. 2004 Sep 7;110(10):1178-9
pubmed: 15353510
Appl Microbiol Biotechnol. 2014;98(14):6205-13
pubmed: 24841116
Immunogenetics. 1994;40(2):129-34
pubmed: 8026862
Front Immunol. 2019 Jun 25;10:1418
pubmed: 31293582
Front Immunol. 2020 Nov 03;11:561724
pubmed: 33224135
Indian J Exp Biol. 2006 May;44(5):349-56
pubmed: 16708886
J Biochem. 2000 Mar;127(3):493-501
pubmed: 10731722
Antioxid Redox Signal. 2018 Nov 10;29(14):1415-1431
pubmed: 29088923
J Allergy Clin Immunol. 2018 Aug;142(2):669-672.e7
pubmed: 29626572
Biochim Biophys Acta. 2011 Jan;1810(1):2-92
pubmed: 20682242
Clin Exp Dermatol. 2015 Apr;40(3):313-7
pubmed: 25683954
Burns. 2010 Dec;36(8):1222-7
pubmed: 20510519
Redox Rep. 2002;7(3):123-30
pubmed: 12189041
PLoS One. 2013 Nov 12;8(11):e79325
pubmed: 24265766
Mol Immunol. 2002 Feb;38(10):765-72
pubmed: 11841836
Surgery. 2018 Nov;164(5):1077-1086
pubmed: 30131176
EMBO J. 1989 Mar;8(3):757-64
pubmed: 2785919
Clin Rev Allergy Immunol. 2018 Feb;54(1):1-25
pubmed: 29313220
Annu Rev Biochem. 1985;54:237-71
pubmed: 3896121
Fibrogenesis Tissue Repair. 2012 Jun 06;5(Suppl 1):S4
pubmed: 23259696
PLoS One. 2015 Jul 01;10(7):e0130350
pubmed: 26132846
Pancreas. 2006 Apr;32(3):264-70
pubmed: 16628081
J Toxicol Environ Health A. 2007 Dec;70(23):1977-85
pubmed: 17966069
Am J Physiol Regul Integr Comp Physiol. 2020 May 1;318(5):R1004-R1013
pubmed: 32292063
J Exp Med. 1999 Jun 7;189(11):1783-9
pubmed: 10359582
Mol Cells. 2016 Jan;39(1):60-4
pubmed: 26813661
J Biol Chem. 1992 Dec 5;267(34):24161-4
pubmed: 1332947
J UOEH. 2012 Mar 1;34(1):27-39
pubmed: 22428456
Redox Biol. 2020 Jul;34:101570
pubmed: 32473461
Biomol Ther (Seoul). 2014 Nov;22(6):477-90
pubmed: 25489414
Mediators Inflamm. 2014;2014:469358
pubmed: 25024510
Sci Rep. 2019 Dec 27;9(1):19958
pubmed: 31882837
J Eur Acad Dermatol Venereol. 2013 Apr;27(4):465-7
pubmed: 22324759
Mech Ageing Dev. 2019 Dec;184:111174
pubmed: 31678215
Circulation. 2004 Sep 7;110(10):1276-83
pubmed: 15337697
Biochim Biophys Acta. 2005 Jan 17;1703(2):93-109
pubmed: 15680218
J Basic Clin Physiol Pharmacol. 2003;14(1):31-42
pubmed: 12901444
Diabetes Metab Res Rev. 2011 Nov;27(8):809-12
pubmed: 22069264
Skin Pharmacol Physiol. 2016;29(5):257-265
pubmed: 27811481

Auteurs

P Sliwiak (P)

Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany.

E Folwarczny (E)

Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany.

D Didona (D)

Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany.

S Fink (S)

Department of Dermatology, Jena University Medical Center, Jena, Germany.

C Wiegand (C)

Department of Dermatology, Jena University Medical Center, Jena, Germany.

E M Hanschmann (EM)

Department of Neurology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

M Hertl (M)

Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany.

C Hudemann (C)

Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH